Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (211-220 of 403) with videos related to

Pageof 41
Sort By:
Supportive Cancer Therapy|July 18, 2008
Rapid and sustained influence of intravenous zoledronic Acid on course of pain and analgesics consumption in patients with cancer with bone metastases: a multicenter open-label study over 1 yearAlbrecht Kretzschmar, Thomas Wiege, Salah-Eddin Al-Batran, et al.
Haematologica|October 27, 2018
Haploidentical <i>versus</i> unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMTEolia Brissot, Myriam Labopin, Gerhard Ehninger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2012
Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cellsAnja Feldmann, Claudia Arndt, Katrin Töpfer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2011
Retargeting of human regulatory T cells by single-chain bispecific antibodiesStefanie Koristka, Marc Cartellieri, Anke Theil, et al.
Molecular Immunology|October 22, 2011
Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker moduleSlava Stamova, Marc Cartellieri, Anja Feldmann, et al.
Journal of Cancer Research and Clinical Oncology|June 27, 2021
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 yearsSabine Kürzel, André-René Blaudszun, Lilly Stahl, et al.
Haematologica|September 7, 2014
Induction of short-term remission with single agent eltrombopag in refractory nucleophosmin-1-mutated acute myeloid leukemiaUwe Platzbecker, Katja Sockel, Claudia Schönefeldt, et al.
Transplantation|October 24, 2014
Pretransplant metabolic distress predicts relapse of acute myeloid leukemia after allogeneic stem cell transplantationSascha Dietrich, Aleksandar Radujkovic, Friedrich Stölzel, et al.
Genes, Chromosomes & Cancer|January 13, 2005
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutationsStefan Fröhling, Richard F Schlenk, Jürgen Krauter, et al.
Annals of Hematology|March 26, 2009
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004Ulrike Bacher, Evgeny Klyuchnikov, Tatjana Zabelina, et al.
Pageof 41

Showing results (211-220 of 403) with videos related to

Sort By:
Pageof 41
Supportive Cancer Therapy|July 18, 2008
Rapid and sustained influence of intravenous zoledronic Acid on course of pain and analgesics consumption in patients with cancer with bone metastases: a multicenter open-label study over 1 yearAlbrecht Kretzschmar, Thomas Wiege, Salah-Eddin Al-Batran, et al.
Haematologica|October 27, 2018
Haploidentical <i>versus</i> unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMTEolia Brissot, Myriam Labopin, Gerhard Ehninger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2012
Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cellsAnja Feldmann, Claudia Arndt, Katrin Töpfer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2011
Retargeting of human regulatory T cells by single-chain bispecific antibodiesStefanie Koristka, Marc Cartellieri, Anke Theil, et al.
Molecular Immunology|October 22, 2011
Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker moduleSlava Stamova, Marc Cartellieri, Anja Feldmann, et al.
Journal of Cancer Research and Clinical Oncology|June 27, 2021
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 yearsSabine Kürzel, André-René Blaudszun, Lilly Stahl, et al.
Haematologica|September 7, 2014
Induction of short-term remission with single agent eltrombopag in refractory nucleophosmin-1-mutated acute myeloid leukemiaUwe Platzbecker, Katja Sockel, Claudia Schönefeldt, et al.
Transplantation|October 24, 2014
Pretransplant metabolic distress predicts relapse of acute myeloid leukemia after allogeneic stem cell transplantationSascha Dietrich, Aleksandar Radujkovic, Friedrich Stölzel, et al.
Genes, Chromosomes & Cancer|January 13, 2005
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutationsStefan Fröhling, Richard F Schlenk, Jürgen Krauter, et al.
Annals of Hematology|March 26, 2009
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004Ulrike Bacher, Evgeny Klyuchnikov, Tatjana Zabelina, et al.
Pageof 41